BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 25447585)

  • 1. Reliability of diagnostic criteria for bronchiolitis obliterans syndrome after lung transplantation: a survey.
    Kapila A; Baz MA; Valentine VG; Bhorade SM;
    J Heart Lung Transplant; 2015 Jan; 34(1):65-74. PubMed ID: 25447585
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bronchiolitis obliterans syndrome-free survival after lung transplantation: An International Society for Heart and Lung Transplantation Thoracic Transplant Registry analysis.
    Kulkarni HS; Cherikh WS; Chambers DC; Garcia VC; Hachem RR; Kreisel D; Puri V; Kozower BD; Byers DE; Witt CA; Alexander-Brett J; Aguilar PR; Tague LK; Furuya Y; Patterson GA; Trulock EP; Yusen RD
    J Heart Lung Transplant; 2019 Jan; 38(1):5-16. PubMed ID: 30391193
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence and outcome of bronchiolitis obliterans syndrome after lung transplantation. Washington University Lung Transplant Group.
    Sundaresan S; Trulock EP; Mohanakumar T; Cooper JD; Patterson GA
    Ann Thorac Surg; 1995 Nov; 60(5):1341-6; discussion 1346-7. PubMed ID: 8526624
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic significance of early pulmonary function changes after onset of chronic lung allograft dysfunction.
    Todd JL; Neely ML; Finlen Copeland CA; Frankel CW; Reynolds JM; Palmer SM
    J Heart Lung Transplant; 2019 Feb; 38(2):184-193. PubMed ID: 30466803
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Restrictive allograft syndrome (RAS): a novel form of chronic lung allograft dysfunction.
    Sato M; Waddell TK; Wagnetz U; Roberts HC; Hwang DM; Haroon A; Wagnetz D; Chaparro C; Singer LG; Hutcheon MA; Keshavjee S
    J Heart Lung Transplant; 2011 Jul; 30(7):735-42. PubMed ID: 21419659
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapy options for chronic lung allograft dysfunction-bronchiolitis obliterans syndrome following first-line immunosuppressive strategies: A systematic review.
    Benden C; Haughton M; Leonard S; Huber LC
    J Heart Lung Transplant; 2017 Sep; 36(9):921-933. PubMed ID: 28662986
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of lung function interpretation approach on pediatric bronchiolitis obliterans syndrome diagnosis after lung transplantation.
    Robinson PD; Spencer H; Aurora P
    J Heart Lung Transplant; 2015 Aug; 34(8):1082-8. PubMed ID: 25979626
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Time-dependent changes in the risk of death in pure bronchiolitis obliterans syndrome (BOS).
    Sato M; Ohmori-Matsuda K; Saito T; Matsuda Y; Hwang DM; Waddell TK; Singer LG; Keshavjee S
    J Heart Lung Transplant; 2013 May; 32(5):484-91. PubMed ID: 23433813
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Single lung transplantation for chronic obstructive pulmonary disease: pulmonary function and impact of bronchiolitis obliterans syndrome.
    Bjørtuft O; Geiran OR; Fjeld J; Skovlund E; Johansen B; Boe J
    Respir Med; 1996 Oct; 90(9):553-9. PubMed ID: 8984530
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An international ISHLT/ATS/ERS clinical practice guideline: diagnosis and management of bronchiolitis obliterans syndrome.
    Meyer KC; Raghu G; Verleden GM; Corris PA; Aurora P; Wilson KC; Brozek J; Glanville AR; ;
    Eur Respir J; 2014 Dec; 44(6):1479-503. PubMed ID: 25359357
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Validation of a post-transplant chronic lung allograft dysfunction classification system.
    Van Herck A; Verleden SE; Sacreas A; Heigl T; Vanaudenaerde BM; Dupont LJ; Yserbyt J; Verbeken EK; Neyrinck AP; Van Raemdonck D; Verleden GM; Vos R
    J Heart Lung Transplant; 2019 Feb; 38(2):166-173. PubMed ID: 30391199
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A new classification system for chronic lung allograft dysfunction.
    Verleden GM; Raghu G; Meyer KC; Glanville AR; Corris P
    J Heart Lung Transplant; 2014 Feb; 33(2):127-33. PubMed ID: 24374027
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low-dose computed tomography volumetry for subtyping chronic lung allograft dysfunction.
    Saito T; Horie M; Sato M; Nakajima D; Shoushtarizadeh H; Binnie M; Azad S; Hwang DM; Machuca TN; Waddell TK; Singer LG; Cypel M; Liu M; Paul NS; Keshavjee S
    J Heart Lung Transplant; 2016 Jan; 35(1):59-66. PubMed ID: 26342441
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term pulmonary function testing in pediatric bronchiolitis obliterans syndrome after hematopoietic stem cell transplantation.
    Walther S; Rettinger E; Maurer HM; Pommerening H; Jarisch A; Sörensen J; Schubert R; Berres M; Bader P; Zielen S; Jerkic SP
    Pediatr Pulmonol; 2020 Jul; 55(7):1725-1735. PubMed ID: 32369682
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of Forced Expiratory Volume in 1 Second (FEV1) and 6-Minute Walking Distance at 3, 6, and 12 Months and Annually on Survival and Occurrence of Bronchiolitis Obliterans Syndrome (BOS) After Lung Transplantation.
    Fakhro M; Ingemansson R; Algotsson L; Lindstedt S
    Ann Transplant; 2017 Sep; 22():532-540. PubMed ID: 28871078
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current views on chronic rejection after lung transplantation.
    Verleden GM; Vos R; Vanaudenaerde B; Dupont L; Yserbyt J; Van Raemdonck D; Verleden S
    Transpl Int; 2015 Oct; 28(10):1131-9. PubMed ID: 25857869
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early Post-Transplantation Spirometry Is Associated with the Development of Bronchiolitis Obliterans Syndrome after Allogeneic Hematopoietic Cell Transplantation.
    Jamani K; He Q; Liu Y; Davis C; Hubbard J; Schoch G; Lee SJ; Gooley T; Flowers MED; Cheng GS
    Biol Blood Marrow Transplant; 2020 May; 26(5):943-948. PubMed ID: 31821885
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Post-transplant baseline FEV1 and the development of bronchiolitis obliterans syndrome: an important confounder?
    Burton CM; Iversen M; Mortensen J; Carlsen J; Andersen CB; Milman N; Scheike T
    J Heart Lung Transplant; 2007 Nov; 26(11):1127-34. PubMed ID: 18022078
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Course of FEV(1) after onset of bronchiolitis obliterans syndrome in lung transplant recipients.
    Lama VN; Murray S; Lonigro RJ; Toews GB; Chang A; Lau C; Flint A; Chan KM; Martinez FJ
    Am J Respir Crit Care Med; 2007 Jun; 175(11):1192-8. PubMed ID: 17347496
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lung Function Trajectory in Bronchiolitis Obliterans Syndrome after Allogeneic Hematopoietic Cell Transplant.
    Cheng GS; Storer B; Chien JW; Jagasia M; Hubbard JJ; Burns L; Ho VT; Pidala J; Palmer J; Johnston L; Mayer S; Crothers K; Pusic I; Lee SJ; Williams KM
    Ann Am Thorac Soc; 2016 Nov; 13(11):1932-1939. PubMed ID: 27513368
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.